We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
-$256K
Cap. Flow
-$1.86M
Cap. Flow %
-1.78%
Top 10 Hldgs %
22.2%
Holding
64
New
2
Increased
1
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
AOS icon
A.O. Smith
AOS
+$1.99M
2
KMB icon
Kimberly-Clark
KMB
+$1.81M
3
MRK icon
Merck
MRK
+$348K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$1.66M
2
TRP icon
TC Energy
TRP
+$1.36M
3
GILD icon
Gilead Sciences
GILD
+$258K
4
ORI icon
Old Republic International
ORI
+$258K
5
JPM icon
JPMorgan Chase
JPM
+$213K

Sector Composition

Rank Sector Weight
1 Financials 24.84%
2 Healthcare 14.89%
3 Industrials 12.89%
4 Consumer Staples 8.63%
5 Technology 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMN icon
51
Eastman Chemical
EMN
$8.55B
$1.2M 1.15%
13,620
-328
-2% -$31K
LYB icon
52
LyondellBasell Industries
LYB
$20.7B
$1.2M 1.15%
17,015
-404
-2% -$30.4K
JNJ icon
53
Johnson & Johnson
JNJ
$626B
$1.18M 1.13%
7,128
-240
-3% -$37.6K
SIRI icon
54
SiriusXM
SIRI
$9.61B
$1.11M 1.06%
49,129
-1,180
-2% -$27.8K
BBY icon
55
Best Buy
BBY
$17.6B
$1.1M 1.06%
15,022
-362
-2% -$29.8K
OHI icon
56
Omega Healthcare
OHI
$13.8B
$1.09M 1.04%
28,530
-677
-2% -$25.2K
TFC icon
57
Truist Financial
TFC
$63.9B
$921K 0.88%
22,393
-540
-2% -$24.1K
BEN icon
58
Franklin Resources
BEN
$16.9B
$898K 0.86%
46,661
-1,142
-2% -$22.9K
CAH icon
59
Cardinal Health
CAH
$56.3B
$795K 0.76%
5,771
-487
-8% -$62.1K
AES icon
60
AES
AES
$10.5B
$701K 0.67%
56,515
-1,377
-2% -$15.9K
TROW icon
61
T. Rowe Price
TROW
$24.3B
$697K 0.67%
7,586
-182
-2% -$19.2K
CI icon
62
Cigna
CI
$72.4B
$612K 0.59%
1,859
TRP icon
63
TC Energy
TRP
$66.3B
-29,237
Closed -$1.36M
UL icon
64
Unilever
UL
$134B
-26,043
Closed -$1.66M

Similar funds

Weaver C. Barksdale & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Weaver C. Barksdale & Associates held 64 positions worth $104M, down 0.24% from $104M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Weaver C. Barksdale & Associates's Q1 2025 filing shows 2 new, 1 increased, 58 reduced and 2 closed positions. Its largest new stake was A.O. Smith: 29,422 shares worth $1.92M. The largest sale was Unilever, an estimated $1.66M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q1 2025 buy was A.O. Smith: 29,422 shares worth $1.92M.
  • Weaver C. Barksdale & Associates added most to Merck in Q1 2025, an estimated $348K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $258K.
  • Weaver C. Barksdale & Associates fully exited Unilever in Q1 2025, selling an estimated $1.66M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $104M portfolio in Q1 2025.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q1 2025.
  • Weaver C. Barksdale & Associates's portfolio value fell 0.24% quarter-over-quarter to $104M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2025, filed 14 May 2025.